JC204 Submitted by ناشناس (تایید نشده) on 6 October 2021 Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial تاریخ ارائه 1397/08/19 تفسیر آماری
